These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


392 related items for PubMed ID: 8842585

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
    Au CL, Affandi B, Rogers PA.
    Contraception; 1994 Nov; 50(5):477-89. PubMed ID: 7859456
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
    Witjaksono J, Lau TM, Affandi B, Rogers PA.
    Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
    [Abstract] [Full Text] [Related]

  • 7. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
    Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF.
    Contraception; 1999 Jul; 60(1):1-8. PubMed ID: 10549446
    [Abstract] [Full Text] [Related]

  • 8. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research.
    Datey S, Gaur LN, Saxena BN.
    Contraception; 1995 Mar; 51(3):155-65. PubMed ID: 7621684
    [Abstract] [Full Text] [Related]

  • 9. Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant.
    Wonodirekso S, Au CL, Hadisaputra W, Affandi B, Rogers PA.
    Contraception; 1993 Nov; 48(5):481-93. PubMed ID: 7506133
    [Abstract] [Full Text] [Related]

  • 10. Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception.
    Buckshee K, Chatterjee P, Dhall GI, Hazra MN, Kodkany BS, Lalitha K, Logambal A, Manchanda P, Nanda UK, RaiChoudhury G.
    Contraception; 1995 Apr; 51(4):237-42. PubMed ID: 7796589
    [Abstract] [Full Text] [Related]

  • 11. Phase III clinical trial with Norplant II (two covered rods): report on five years of use.
    Contraception; 1993 Aug; 48(2):120-32. PubMed ID: 8403909
    [Abstract] [Full Text] [Related]

  • 12. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM.
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [Abstract] [Full Text] [Related]

  • 13. Management of irregular uterine bleeding and spotting associated with Norplant.
    Archer DF, Philput CA, Weber ME.
    Hum Reprod; 1996 Oct; 11 Suppl 2():24-30. PubMed ID: 8982742
    [Abstract] [Full Text] [Related]

  • 14. Norplant subdermal contraceptive system: experience in Taiwan.
    Tseng LH, Lee TY, Yang YS, Ko TM, Chuang SM.
    Contraception; 1996 Mar; 53(3):177-80. PubMed ID: 8689883
    [Abstract] [Full Text] [Related]

  • 15. Experience of Thai women in Bangkok with Norplant-2 implants.
    Chompootaweep S, Kochagarn E, Tang-Usaha J, Theppitaksak B, Dusitsin N.
    Contraception; 1998 Oct; 58(4):221-5. PubMed ID: 9866003
    [Abstract] [Full Text] [Related]

  • 16. Hormonal treatment for bleeding irregularities in Norplant implant users.
    Alvarez-Sanchez F, Brache V, Thevenin F, Cochon L, Faundes A.
    Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
    [Abstract] [Full Text] [Related]

  • 17. Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study.
    Hickey M, Fraser I, Dwarte D, Graham S.
    Hum Reprod; 1996 Oct; 11 Suppl 2():35-44. PubMed ID: 8982744
    [Abstract] [Full Text] [Related]

  • 18. Experience with side effects and health risks associated with Norplant implant use in adolescents.
    Rosenthal SL, Biro FM, Kollar LM, Hillard PJ, Rauh JL.
    Contraception; 1995 Nov; 52(5):283-5. PubMed ID: 8585884
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
    Marsh MM, Butt AR, Riley SC, Rogers PA, Susil B, Affandi B, Findlay JK, Salamonsen LA.
    Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.